Tuning immune tolerance with vasoactive intestinal peptide: A new therapeutic approach for immune disorders
- 1 September 2007
- Vol. 28 (9) , 1833-1846
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- Regulatory effects of vasoactive intestinal peptide on the migration of mature dendritic cellsJournal of Neuroimmunology, 2007
- Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cellsBlood, 2006
- Neural regulation of innate immunity: a coordinated nonspecific host response to pathogensNature Reviews Immunology, 2006
- Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjögren's syndromeAnnals of the Rheumatic Diseases, 2006
- Effective treatment of collagen‐induced arthritis by adoptive transfer of CD25+ regulatory T cellsArthritis & Rheumatism, 2005
- Time-course expression of Toll-like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIPJournal of Leukocyte Biology, 2005
- The immune system as the sixth senseJournal of Internal Medicine, 2005
- Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα TherapyJournal of Experimental Medicine, 2004
- Dendritic cells: emerging pharmacological targets of immunosuppressive drugsNature Reviews Immunology, 2004
- VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNγ synthesis by T cellsJournal of Neuroimmunology, 1999